The New England Journal of Medicine

The New England Journal of Medicine
Share

The New England Journal of Medicine

 •  December 6, 2017

The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheter-directed thrombolysis (hereafter “pharmacomechanical thrombolysis”) rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome. We randomly...

The New England Journal of Medicine

 •  December 30, 2015

To the Editor: Pemphigus vulgaris is a potentially fatal autoimmune blistering disease that affects the skin and mucous membranes.1 Dramatic improvement has been observed with the use of rituximab and the protocols for lymphoma or rheumatoid arthritis. In these studies, patients with either condition were simultaneously treated with systemic...

The New England Journal of Medicine

 •  October 13, 2015

BENZATHINE penicillin (N,N′-dibenzylethylenediamine dipenicillin G) is a long-acting repository penicillin that provides low serum penicillin levels for three or four weeks after a single intramuscular injection of 1,200,000 units.1 It has been shown to ...